Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1982-07-08
1984-12-18
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
424177, 424317, A61K 3120, A61K 3119, A61K 3700
Patent
active
044890974
ABSTRACT:
Antifungal/antibacterial materials are added to sterile compositions intended for administration to humans or lower animals to minimize bacterial and mycotic contamination which can cause infections associated with the medical and veterinary use of such compositions.
REFERENCES:
patent: 3404987 (1968-10-01), Kooistra et al.
patent: 3743519 (1973-07-01), Haas
patent: 3767803 (1973-10-01), Nurnberg
patent: 3873720 (1975-03-01), Suzuki et al.
Remington's Pharmaceutical Sciences, 13th ed. Mack Publishing Co. Easton, Pa. (1965), pp. 501-502.
Ann. Surg., Sep., 1972, pp. 265-272.
Doctoral Dissertation of R. L. Stone-p. 37.
Antibiotics and Chemotherapy, vol. V, No. 5 (May, 1955), pp. 255-262.
Chemical Abstracts, vol. 75 (1971):95737f.
Georges, Arch. Belges. Derm. Syph. 9/1:1-13 (1953).
Goldstein Steven J.
Rasser Jacobus C.
The Procter & Gamble & Company
Waddell Frederick E.
Yetter Jerry J.
LandOfFree
Intravenous solutions with antimicrobial agent does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Intravenous solutions with antimicrobial agent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intravenous solutions with antimicrobial agent will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1988450